2 weeks Ago By ABMN Staff
Federated Hermes Inc. raised its holdings in shares of Waters Co. ( NYSE:WAT – Free Report ) by 29.
2% during the 4th quarter, Holdings Channel reports. The fund owned 270 shares of the medical instruments supplier’s stock after purchasing an additional 61 shares during the period. Federated Hermes Inc.
’s holdings in Waters were worth $100,000 as of its most recent filing with the Securities and Exchange Commission (SEC). A number of other hedge funds and other institutional investors have also modified their holdings of WAT. Vanguard Group Inc.
lifted its stake in Waters by 0.3% during the fourth quarter. Vanguard Group Inc.
now owns 7,098,668 shares of the medical instruments supplier’s stock valued at $2,633,464,000 after purchasing an additional 19,456 shares during the last quarter. Wealthfront Advisers LLC grew its holdings in shares of Waters by 106,144.4% during the 4th quarter.
Wealthfront Advisers LLC now owns 3,087,461 shares of the medical instruments supplier’s stock valued at $1,145,386,000 after acquiring an additional 3,084,555 shares in the last quarter. Alliancebernstein L.P.
increased its position in Waters by 8.7% in the 4th quarter. Alliancebernstein L.
P. now owns 2,654,002 shares of the medical instruments supplier’s stock worth $984,582,000 after purchasing an additional 212,364 shares during the last quarter. Geode Capital Management LLC increased its holdings in Waters by 2.
5% in the fourth quarter. Geode Capital Management LLC now owns 1,451,445 shares of the medical instruments supplier’s stock worth $537,053,000 after buying an additional 34,762 shares during the last quarter. Finally, AKO Capital LLP increased its stake in shares of Waters by 3.
2% during the 4th quarter. AKO Capital LLP now owns 815,379 shares of the medical instruments supplier’s stock worth $302,489,000 after purchasing an additional 25,172 shares during the last quarter. 94.
01% of the stock is currently owned by institutional investors. Wall Street Analysts Forecast Growth A number of research analysts recently weighed in on WAT shares. UBS Group raised their price objective on Waters from $405.
00 to $410.00 and gave the company a “neutral” rating in a research note on Thursday, February 13th. Barclays cut their price objective on Waters from $400.
00 to $350.00 and set an “equal weight” rating for the company in a research report on Thursday, April 10th. Scotiabank upgraded Waters from a “sector perform” rating to a “sector outperform” rating and upped their price target for the stock from $430.
00 to $450.00 in a report on Thursday, February 13th. Wells Fargo & Company upped their target price on shares of Waters from $415.
00 to $420.00 and gave the company an “overweight” rating in a research note on Thursday, February 13th. Finally, Baird R W upgraded Waters from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, March 26th.
Ten equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $395.38.
Waters Trading Down 0.1 % NYSE:WAT opened at $320.90 on Friday.
The business has a 50 day moving average price of $360.29 and a two-hundred day moving average price of $371.11.
The company has a quick ratio of 0.65, a current ratio of 0.94 and a debt-to-equity ratio of 1.
14. The company has a market cap of $19.09 billion, a P/E ratio of 29.
96, a price-to-earnings-growth ratio of 3.79 and a beta of 1.04.
Waters Co. has a twelve month low of $279.24 and a twelve month high of $423.
56. Waters ( NYSE:WAT – Get Free Report ) last released its earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.
10 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.02 by $0.08.
Waters had a return on equity of 46.31% and a net margin of 21.56%.
As a group, analysts expect that Waters Co. will post 12.86 EPS for the current fiscal year.
About Waters ( Free Report ) Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Further Reading Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. ( NYSE:WAT – Free Report ).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter ..
